Eli Lilly in the Drug Discovery & Development Pharma 50

Analysts are bullish on Eli Lilly with its ‘transformative’ drugs

AstraZeneca

Ultomiris wins approval in Europe for generalized myasthenia gravis

Ensysce

Women in Pharma: Ensysce Biosciences’ CEO aims to combat prescription drug abuse

FDA logo

FDA releases draft guidance to protect children in clinical trials

Bionanotech

BioNanoTech aims to usher in new frontier in protein purification

MindMed

MindMed announces Phase 1 study of MDMA-like substances

Dr. Susan Galbraith

Women in Pharma: AstraZeneca executive vice president Susan Galbraith has helped develop seven blockbuster drugs

CytoReason-Pfizer

Pfizer and AI firm CytoReason extend alliance

Cleveland

Ohio grows into a globally recognized R&D hub